Cardiogenic shock Percutaneous Coronary Intervention

Jump to navigation Jump to search

Cardiogenic Shock Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiogenic shock from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiogenic shock Percutaneous Coronary Intervention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiogenic shock Percutaneous Coronary Intervention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiogenic shock Percutaneous Coronary Intervention

CDC on Cardiogenic shock Percutaneous Coronary Intervention

Cardiogenic shock Percutaneous Coronary Intervention in the news

Blogs on Cardiogenic shock Percutaneous Coronary Intervention

Directions to Hospitals Treating Cardiogenic shock

Risk calculators and risk factors for Cardiogenic shock Percutaneous Coronary Intervention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [6]

2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention (DO NOT EDIT)[1]

PCI in patients with Cardiogenic Shock (DO NOT EDIT)[1]

Class I
"1. PCI is recommended for patients with acute myocardial infarction who developcardiogenic shock and are suitable candidates.[2][3][4][5] (Level of Evidence: B)"
"2. A hemodynamic support device is recommended for patients with cardiogenic shock afterSTEMI who do not quickly stabilize with pharmacological therapy.[2][6][7][8][9](Level of Evidence: B)"

References

  1. ↑ 1.0 1.1 Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011). "2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" (PDF). Journal of the American College of Cardiology. 58 (24): 2550–83. doi:10.1016/j.jacc.2011.08.006. PMID 22070837. Retrieved 2011-12-08. Text "PDF" ignored (help); Unknown parameter |month= ignored (help)
  2. ↑ 2.0 2.1 Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD et al. (1999)Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 341 (9):625-34.DOI:10.1056/NEJM199908263410901PMID:10460813
  3. ↑ Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V et al. (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285 (2):190-2. PMID: [1]
  4. ↑ Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P et al. (2006)Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295 (21):2511-5.[2] PMID:16757723
  5. ↑ Urban P, Stauffer JC, Bleed D, Khatchatrian N, Amann W, Bertel O et al. (1999)A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J 20 (14):1030-8.DOI:10.1053/euhj.1998.1353 PMID:10383377
  6. ↑ Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK et al. (2000)Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36 (3 Suppl A):1123-9. PMID:10985715
  7. ↑ Chen EW, Canto JG, Parsons LS, Peterson ED, Littrell KA, Every NR et al. (2003)Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation108 (8):951-7. [3] PMID: [4]
  8. ↑ Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM et al. (2001)The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 141 (6):933-9.DOI:10.1067/mhj.2001.115295PMID:11376306
  9. ↑ Reynolds HR, Hochman JS (2008)Cardiogenic shock: current concepts and improving outcomes. Circulation 117 (5):686-97. [5] PMID: 18250279

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Cardiogenic_shock_Percutaneous_Coronary_Intervention&oldid=789533"